Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea R Shiakolas

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Nature Communications|June 17, 2022
Single-cell profiling of the antigen-specific response to BNT162b2 SARS-CoV-2 RNA vaccineKevin J Kramer, Erin M Wilfong, Kelsey Voss, et al.
Biorxiv : the Preprint Server for Biology|August 3, 2021
Single-Cell Profiling of the Antigen-Specific Response to BNT162b2 SARS-CoV-2 RNA VaccineKevin J Kramer, Erin M Wilfong, Kelsey Voss, et al.
Cell Reports|September 30, 2021
Potent neutralization of SARS-CoV-2 variants of concern by an antibody with an uncommon genetic signature and structural mode of spike recognitionKevin J Kramer, Nicole V Johnson, Andrea R Shiakolas, et al.
Cell Reports. Medicine|May 31, 2021
Cross-reactive coronavirus antibodies with diverse epitope specificities and Fc effector functionsAndrea R Shiakolas, Kevin J Kramer, Daniel Wrapp, et al.
Biorxiv : the Preprint Server for Biology|January 31, 2024
Discovery and Characterization of a Pan-betacoronavirus S2-binding antibodyNicole V Johnson, Steven C Wall, Kevin J Kramer, et al.
Biorxiv : the Preprint Server for Biology|January 5, 2021
Cross-reactive coronavirus antibodies with diverse epitope specificities and extra-neutralization functionsAndrea R Shiakolas, Kevin J Kramer, Daniel Wrapp, et al.
Structure (London, England : 1993)|September 26, 2024
Discovery and characterization of a pan-betacoronavirus S2-binding antibodyNicole V Johnson, Steven C Wall, Kevin J Kramer, et al.
Plos Pathogens|September 18, 2024
Isolation and characterization of IgG3 glycan-targeting antibodies with exceptional cross-reactivity for diverse viral familiesMatthew J Vukovich, Andrea R Shiakolas, Jared Lindenberger, et al.
Cell Reports|January 28, 2023
Functional HIV-1/HCV cross-reactive antibodies isolated from a chronically co-infected donorKelsey A Pilewski, Steven Wall, Simone I Richardson, et al.
The New England Journal of Medicine|December 14, 2016
Effect of HIV Antibody VRC01 on Viral Rebound after Treatment InterruptionKatharine J Bar, Michael C Sneller, Linda J Harrison, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Nature Communications|June 17, 2022
Single-cell profiling of the antigen-specific response to BNT162b2 SARS-CoV-2 RNA vaccineKevin J Kramer, Erin M Wilfong, Kelsey Voss, et al.
Biorxiv : the Preprint Server for Biology|August 3, 2021
Single-Cell Profiling of the Antigen-Specific Response to BNT162b2 SARS-CoV-2 RNA VaccineKevin J Kramer, Erin M Wilfong, Kelsey Voss, et al.
Cell Reports|September 30, 2021
Potent neutralization of SARS-CoV-2 variants of concern by an antibody with an uncommon genetic signature and structural mode of spike recognitionKevin J Kramer, Nicole V Johnson, Andrea R Shiakolas, et al.
Cell Reports. Medicine|May 31, 2021
Cross-reactive coronavirus antibodies with diverse epitope specificities and Fc effector functionsAndrea R Shiakolas, Kevin J Kramer, Daniel Wrapp, et al.
Biorxiv : the Preprint Server for Biology|January 31, 2024
Discovery and Characterization of a Pan-betacoronavirus S2-binding antibodyNicole V Johnson, Steven C Wall, Kevin J Kramer, et al.
Biorxiv : the Preprint Server for Biology|January 5, 2021
Cross-reactive coronavirus antibodies with diverse epitope specificities and extra-neutralization functionsAndrea R Shiakolas, Kevin J Kramer, Daniel Wrapp, et al.
Structure (London, England : 1993)|September 26, 2024
Discovery and characterization of a pan-betacoronavirus S2-binding antibodyNicole V Johnson, Steven C Wall, Kevin J Kramer, et al.
Plos Pathogens|September 18, 2024
Isolation and characterization of IgG3 glycan-targeting antibodies with exceptional cross-reactivity for diverse viral familiesMatthew J Vukovich, Andrea R Shiakolas, Jared Lindenberger, et al.
Cell Reports|January 28, 2023
Functional HIV-1/HCV cross-reactive antibodies isolated from a chronically co-infected donorKelsey A Pilewski, Steven Wall, Simone I Richardson, et al.
The New England Journal of Medicine|December 14, 2016
Effect of HIV Antibody VRC01 on Viral Rebound after Treatment InterruptionKatharine J Bar, Michael C Sneller, Linda J Harrison, et al.
Pageof 3